Q2 FY2026 · ended Jun 30, 2026 · Revenue $3.80M, +115.9% YoY · Filed Aug 17, 2026
Charlie’s Holdings, Inc. (CHUC) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $3.8 million and a net loss of $1.7 million. As of Jun 30, 2026 it held $527,000 in cash and investments and $514,000 in total debt.
Revenue
$3.80M
+115.9% vs year-ago quarter
Net income
$-1.66M
-133.5% vs year-ago quarter
Operating cash flow
$-383,000
+85.6% vs year-ago quarter
Free cash flow
—
EPS
$0.00
+110.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
280.55M
+6.9% vs year-ago quarter
Net cash
$13,000
Q2 FY2026
Operating margin
-9.7%
TTM
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CHUC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Costa Mesa, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1134765
- Former names
- True Drinks Holdings, Inc. (until Jul 2, 2019); BAZI INTERNATIONAL, INC. (until Jan 22, 2013); XELR8 HOLDINGS, INC. (until Aug 2, 2010); VITACUBE SYSTEMS HOLDINGS INC (until Mar 9, 2007); INSTANET INC (until Mar 30, 2004)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.8M | $4.8M | $9.0M | $7.1M | $1.8M |
| Operating income | -$1.2M | -$975,000 | -$123,000 | -$339,000 | -$954,000 |
| Net income | -$1.7M | -$1.1M | $131,000 | $624,000 | $5.0M |
| Diluted EPS | — | — | $0.00 | $0.00 | $0.00 |
| Operating cash flow | -$383,000 | -$1.1M | $394,000 | -$3.1M | -$2.7M |
| Total assets | $12.8M | $14.8M | $11.6M | $10.6M | $6.0M |
| Total liabilities | $9.7M | $11.7M | $8.1M | $7.3M | $3.8M |
| Stockholders' equity | $3.1M | $3.1M | $3.4M | $3.2M | $2.2M |
| Cash and investments | $527,000 | $640,000 | $1.3M | $1.1M | $1.5M |
| Total debt | $514,000 | $576,000 | $636,000 | $570,000 | $0 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 4, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 21, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 1, 2026 | Dec 31, 2025 |
All 820 Charlie’s Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.